PR Newswire - Korea's SK bioscience Acquires Stake in U.S. Biote...
SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bioscience expects to improve the immunogenici...
Read More

ภาษาไทย
English